Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals reports revenues of $2M
Published in Pharma Investments, Ventures and Law Weekly, April 2nd, 2006
"The fourth quarter concluded a transformative year for Anadys, highlighted in June 2005 by our significant collaboration agreement with Novartis for ANA975 in hepatitis C and hepatitis B and marked by continuing progress in our clinical development programs," said Kleanthis G. Xanthopoulos, PhD, Anadys' president and CEO.
"Through our partnership with Novartis, we have placed the ANA975 program on firm clinical developmental and strategic pathways. In addition, we have selected ANA773, a novel Toll-Like Receptor-7 (TLR-7)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- Acadia Pharmaceuticals, Inc.
Acadia Pharmaceuticals reports loss of $10.2M - Advaxis, Inc.
Fredrick D. Cobb appointed vice president of finance at Advaxis - Aksys, Ltd.
Aksys expects to report loss of $0.22 per share - Amgen
Amgen donates $1.1M to The Wellness Community - Amicas, Inc.
Amicas reports 17% increase in revenue - Antares Pharma, Inc.
Antares to raise approximately $11M in a private placement - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
